Jilin Zhengye Biotechnology (ZYBT) - Multiplikator forward rega marang pendapatan

The development of livestock vaccines that reduce antibiotic use confirms the high credit standing of Zhengye Biotechnology (ZYBT). The forward price-to-sales ratio demonstrates stable dynamics, where 2.90 represents the current metric. Financial stability is bolstered by strict bio-waste control and wastewater treatment, as well as an impeccable reputation as an expert in veterinary pharmaceuticals trusted by farmers.

jlzybio.com - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ZYBT (periode 08.01.2025 - 15.11.2026)

Rincian metrik komprehensif lan analitis jlzybio.com (ZYBT)

- rega saham lan target rega konsensus:

Kutipan saham Zhengye Bio|ZYBT - Konsensus nilai wajar

- indikator kapitalisasi pasar:

Biji pasar Zhengye Corp|ZYBT - Total Nilai Bisnis

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Zhengye Biotechnology|ZYBT - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku jlzybio.com|ZYBT - Gunggung Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

- rincian asil keuangan lan kelipatan valuasi:

ZYBT - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep Zhengye Biotechnology|ZYBT - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Jilin Zhengye Biotechnology|ZYBT - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Zhengye Biotechnology|ZYBT - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham (EPS TTM) Zhengye Biotechnology|ZYBT - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan jlzybio.com|ZYBT - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Zhengye Biotechnology

- rincian pendapatan lan dodolan:

ZYBT - Volume dodolan perusahaan|Prakiraan volume dodolan Jilin Zhengye Biotechnology|ZYBT - Multiplikator rega marang pendapatan|Multiplikator forward rega marang pendapatan Zhengye Corp|ZYBT - Wutah pendapatan taun lumaku

Pambiji fundamental perusahaan:ZYBT (jlzybio.com)

This indicator reflects the market value of Zhengye Biotechnology (ZYBT) relative to its expected sales, allowing investors to determine the extent of the asset's overvaluation. By analyzing the forward price-to-sales ratio, one can assess how currency fluctuations impact the dollar-denominated returns of Zhengye Biotechnology (ZYBT), which develops eco-friendly livestock vaccines aimed at minimizing antibiotic use in agriculture.

Analisis pesaing

IDEXX Lab - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan TRMB|NEOG: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ymt.com|BIOX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep GrowGeneration Corp (GRWG)|RYM (agrify.com) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Cibus Global (CBUS)|Multiplikator Forward P/S WFCF|UAVS (AgEagle Aerial Systems Inc.) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan GrowHub TGHL|iPower Inc (IPW) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|HYFM - Rasio rega marang prakiraan pendapatan|BNC: Rasio rega marang prakiraan pendapatan|urban-gro Inc. (UGRO) - Rasio rega marang prakiraan pendapatan|NITO (N2OFF Corp) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Arcadia Biosciences Corp|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep AgriFORCE Growing Systems AGRI|Multiplikator Forward P/S AGFY|Benson Hill, Inc. (BHIL) - Prakiraan rega marang pendapatan|CEA Industries, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake TIO (Tingo Group, Inc.)